The historical rank and industry rank for China National Accord Medicines's EV-to-FCF or its related term are showing as below:
SZSE:200028'
s EV-to-FCF Range Over the Past 10 Years
Min: -490.35 Med: 13.41 Max: 57.24
Current: 6.37
During the past 13 years, the highest EV-to-FCF of China National Accord Medicines was 57.24. The lowest was -490.35. And the median was 13.41.
SZSE:200028's EV-to-FCF is ranked better than 78.12% of 64
companies
in the Medical Distribution industry
Industry Median: 22.185
vs SZSE:200028: 6.37
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of China National Accord Medicines's EV-to-FCF
For the Medical Distribution subindustry, China National Accord Medicines's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China National Accord Medicines's EV-to-FCF Distribution in the Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, China National Accord Medicines's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where China National Accord Medicines's EV-to-FCF falls into.
China National Accord Medicines EV-to-FCF Calculation
China National Accord Medicines's current Enterprise Value is HK$18,387 Mil.
China National Accord Medicines's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$2,868 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China National Accord Medicines (SZSE:200028) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
China National Accord Medicines's PE Ratio for today is calculated as:
China National Accord Medicines's share price for today is HK$14.62.
China National Accord Medicines's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$3.155.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
China National Accord Medicines EV-to-FCF Related Terms
Thank you for viewing the detailed overview of China National Accord Medicines's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
China National Accord Medicines (SZSE:200028) Business Description
China National Accord Medicines Corp Ltd develops and manufactures pharmaceuticals in China. The company engaged in the wholesale of Chinese patent drugs, traditional Chinese medicines, chemical medicine preparations, antibiotics, biochemical drugs and cerebrovascular system drugs. It operates through the following segments: The Head office segment engages in investing and managing the business; The Pharmaceutical Distribution segment engages in the distribution of medicine and pharmaceutical products to customers, including hospitals, other distributors, retail drug stores, and clinics, and Retail pharmacy segment, which is managing the operation of Guoda Pharmacy. It generates maximum revenue from the Pharmaceutical Distribution segment.
China National Accord Medicines (SZSE:200028) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SZSE:200028 has been successfully added to your 